ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $229,211 | -77.1% | 7,992 | -80.9% | 0.01% | -78.6% |
Q1 2023 | $1,000,532 | +188.1% | 41,741 | +103.8% | 0.04% | +133.3% |
Q4 2022 | $347,307 | -11.6% | 20,478 | -17.9% | 0.02% | +5.9% |
Q2 2022 | $393,000 | -65.1% | 24,954 | -18.0% | 0.02% | -76.1% |
Q4 2021 | $1,126,000 | -23.0% | 30,443 | -14.0% | 0.07% | -48.2% |
Q1 2021 | $1,462,000 | – | 35,400 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |